Phase II study evaluating the efficacy and tolerability of diabetes mellitus vaccine [Diamyd] for the prevention of type 1 diabetes mellitus in adults at high risk
Phase of Trial: Phase II
Latest Information Update: 27 Aug 2009
At a glance
- Drugs GAD65 vaccine (Diamyd) (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 17 Dec 2008 New trial record.